SCHEMBL22012111

SCHEMBL22012111

CC(C)(C)OC(=O)N1CCc2sc(S(=N)(N)=O)cc2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.51
NR1H2 P55055 1/20 0.50
ADORA1 P30542 2/20 0.45
BRD4 O60885 1/20 0.44
CREBBP Q92793 1/20 0.44
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MAPK1 P28482 1/20 0.40
SCN9A Q15858 1/20 0.37
NAMPT P43490 1/20 0.37
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
GRAMD1A Q96CP6 1/20 0.36
GPR119 Q8TDV5 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
PDK4 Q16654 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962422 0.91 NR1H2 (0.52) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL4183295 0.86 ESR2 (0.50) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL21962254 0.83 ESR2 (0.47) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL22012113 0.83 NR1H2 (0.45) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL14876121 0.81 NR1H2 (0.60) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL21962187 0.80 ESR2 (0.44) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL6421569 0.79 ESR2 (0.55) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL6421478 0.79 NR1H2 (0.54) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL22369230 0.78 ESR2 (0.54) ESR2NR1H2ADORA1BRD4CREBBP
SCHEMBL1017283 0.78 ESR2 (0.54) ESR2NR1H2ADORA1BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102576-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed